Tag: Lonza

Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration

28 January 2026 No Comments

In 2025, Lonza1 delivered sales of CHF 6.5 billion with +21.7% CER2 growth, and a CORE

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)

9 October 2025 No Comments

New aseptic state-of-the-art filling line in Stein (CH) designed for biologics and highly potent

Ethris and Lonza Collaborate to Develop Room-Temperature Stable, Spray-Dried mRNA Vaccines

12 May 2025 No Comments

Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), have announced a collaboration to..

Tag: Lonza

Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)

Ethris and Lonza Collaborate to Develop Room-Temperature Stable, Spray-Dried mRNA Vaccines

Login